qvm149
Showing 1 - 5 of 5
Asthma Trial (QVM149, Salmeterol Xinafoate / Fluticasone Propionate, Placebo to QVM149)
Not yet recruiting
- Asthma
- QVM149
- +7 more
- (no location specified)
Mar 18, 2023
Asthma Trial in London (QVM149, High Dose Dual Therapy (ICS/LABA))
Withdrawn
- Asthma
- QVM149
- High Dose Dual Therapy (ICS/LABA)
-
London, Ontario, CanadaRobarts Research Insitute; The University of Western Ontario; Lo
Nov 29, 2021
Asthma Trial in Worldwide (QVM149, Salmeterol/fluticasone plus tiotropium)
Completed
- Asthma
- QVM149
- Salmeterol/fluticasone plus tiotropium
-
Berazategui, Buenos Aires, Argentina
- +162 more
Oct 7, 2021